Literature DB >> 25932192

Role of SB203580 in the regulation of human esophageal cancer cells under the effection of Diosgenin.

Weiliang Ding1, Yancai Jiang2, Yaping Jiang3, Taofeng Zhu4, Ying Xu5, Wenjie Jiang5, Wenjiao Zhu5, Zhian Tang6, Zhijun Ge7, Tieliang Ma5, Yongfei Tan2.   

Abstract

In order to investigate the mechanism of human esophageal Eca109 cells induced by Diosgenin (Dio), the p38 specific inhibitor SB203580 was used to inhibit the expression of p38 and Western blot was employed to detect the effect of SB203580 in Eca109 cells. MTT experiments were executed to detect the proliferation of the cells. Western blot was also applied to find the expression of phosphorylated p38 (p-p38). It is found that SB203580 can inhibit the expression of p38 in human esophageal cell Eca109. After treated with 50 μg/mL of Dio and 10 μg/mL of SB203580, the proliferation of cells showed significantly increase and the apoptosis of cells showed significantly decrease compared with the proliferation in the cells treated with Dio only. Moreover, p-p38 protein level was significantly decreased after treated by the two drugs. It is concluded that Dio may regulate esophageal Eca109 cells through p-p38 pathway.

Entities:  

Keywords:  Diosgenin; SB203580; human esophageal cancer; p38

Year:  2015        PMID: 25932192      PMCID: PMC4402839     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  17 in total

1.  Investigating the relationship between cell cycle stage and diosgenin-induced megakaryocytic differentiation of HEL cells using sedimentation field-flow fractionation.

Authors:  Clementine Cailleteau; Ludovic Micallef; Clemence Lepage; Philippe Jean-Paul Cardot; Jean-Louis Beneytout; Bertrand Liagre; Serge Battu
Journal:  Anal Bioanal Chem       Date:  2010-08-17       Impact factor: 4.142

Review 2.  MAP kinases and the control of nuclear events.

Authors:  A G Turjanski; J P Vaqué; J S Gutkind
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

Review 3.  Differential regulation and properties of MAPKs.

Authors:  M Raman; W Chen; M H Cobb
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

4.  Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.

Authors:  Lijuan Wang; Qiang Meng; Changyuan Wang; Qi Liu; Jinyong Peng; Xiaokui Huo; Huijun Sun; Xiaochi Ma; Kexin Liu
Journal:  J Nat Prod       Date:  2013-04-26       Impact factor: 4.050

5.  Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins.

Authors:  Zhiyu Wang; Yue Cheng; Neng Wang; Dong Mei Wang; Ying Wei Li; Feng Han; Jian Gang Shen; De Po Yang; Xin Yuan Guan; Jian-Ping Chen
Journal:  Cancer Biol Ther       Date:  2012-02-01       Impact factor: 4.742

6.  Anti-tumour and immunomodulating activities of diosgenin, a naturally occurring steroidal saponin.

Authors:  Zhongmei He; Yudan Tian; Xiantao Zhang; Bai Bing; Lianxue Zhang; Huaisheng Wang; Wenjie Zhao
Journal:  Nat Prod Res       Date:  2012-01-11       Impact factor: 2.861

7.  JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells.

Authors:  Bong-Jo Kim; Seung-Wook Ryu; Byoung-Joon Song
Journal:  J Biol Chem       Date:  2006-05-18       Impact factor: 5.157

8.  Diosgenin down-regulates NF-κB p65/p50 and p38MAPK pathways and attenuates acute lung injury induced by lipopolysaccharide in mice.

Authors:  Mengyu Gao; Ling Chen; Haixiang Yu; Qi Sun; Junping Kou; Boyang Yu
Journal:  Int Immunopharmacol       Date:  2012-12-14       Impact factor: 4.932

Review 9.  MAP kinase signalling pathways in cancer.

Authors:  A S Dhillon; S Hagan; O Rath; W Kolch
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

Review 10.  Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin.

Authors:  Jayadev Raju; Rekha Mehta
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

View more
  2 in total

1.  Diosgenin inhibits the epithelial-mesenchymal transition initiation in osteosarcoma cells via the p38MAPK signaling pathway.

Authors:  Huaming Huang; Chao Nie; Xiaokang Qin; Jie Zhou; Lei Zhang
Journal:  Oncol Lett       Date:  2019-08-23       Impact factor: 2.967

2.  The Opposite Expected Effect of p38 Inhibitors on Fat Graft Survival.

Authors:  Simon A Filson; Aviad Keren; Nyra Goldstein; Yehuda Ullmann
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-07-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.